Skip to content

AHA Scientific Sessions 2021

The AHA scientific sessions 2021 will be held from November 13-15, 2021 where more than 15,000 delegates will be meeting virtually. Clinicians, scientists and AHA members, including Mass General experts will gather together and be part of this year's scientific and global education sessions.

It's been 100 years since the American Heart Association (AHA) began supporting and focusing on the advancement of cardiovascular science. The AHA was founded in the year 1924 by six cardiologists and today it has more than a thousand members who have dedicated their knowledge better heart health.

These sessions are aimed at improving cardiovascular health and science. Some of the topics covered throughout the event include:

  • Championing scientific discovery and clinical practices
  • Heart failure guidelines
  • Profiles in cardiovascular diseases
  • Imaging of structural heart interventions
  • The face of critical clinical and other research challenges
  • Managing stable CAD, cardio-oncology and cardiovascular care
  • Valvular heart disease
  • Cardiopulmonary translational science
  • Pulmonary embolism

Presentations at this event will be live-streamed and available on demand.

Presenters and Topics

Mezue K, Zureigat H, Abohashem S, Abbasi T, Gharios C, Cardeiro A, Rosovsky R, Osborne MT, Tawakol A.
Stress-Related Neural Pathways Mediate the Link Between Depression/Anxiety Disorders and Cardiovascular Disease

Neel Butala, MD, MBA
Virtual poster session: Cost-Effectiveness of Bempedoic Acid in Patients with Established Atherosclerotic Cardiovascular Disease

Sam Levine Young Investigator Award Oral Presentation Session: Estimation of DAPT Study Treatment Effects in Contemporary Clinical Practice: Findings from the EXTEND-DAPT Study (this will be coordinated with simultaneous publication of a manuscript in Circulation)

Steven Lubitz, MD, MPH
Fitbit Heart Study

Shaan Khurshid, MD, and Steven Lubitz, MD, MPH
Electrocardiogram-Based Deep Learning and Clinical Risk Factors to Predict Incident Atrial Fibrillation

Mike Honigberg, MD, MPP
Hypercholesterolemia in Young Adults

Malissa Wood, MD
Insights into Spontaneous Coronary Artery Dissection

Aaron Baggish, MD
Approaching CVD Prevention in COVID Long Haulers From Physiology to Practice

Echocardiographic Assessment and Lung Ultrasound in COVID-19 Spectrum of Cardiac Manifestation Risk Assessment and Long-Term Implications

Pradeep Natarajan, MD, MMSc
Secrets to Successful Mentee to Mentor Transitions

Deep Learning of the Retina Enables Phenome- and Genome- Wide Analyses of the Microvasculature

Genome-Wide Pleiotropy Analysis of Coronary Artery Disease and Pneumonia

Thomas Gilliland, MD, and Pradeep Natarajan, MD, MMSc
Genetic Architecture and Clinical Outcomes of the Fredrickson-Levy-Lees Dyslipoproteinemias

Romit Bhattacharya, MD, and Pradeep Natarajan, MD, MMSc
Population Effects of Clinical, Laboratory and Genetic Risk Factors for Incident CAD: A Cohort Study in the UK Biobank

Patrick Ellinor, MD, PhD
Coronary Disease Association with ADAMTS7 is Due to Protease Activity Implications for Therapeutic Development

Nicholas Marston (BWH), Christian Ruff (BWH) and Patrick Ellinor, MD, PhD
Predictive Power and Value of a CAD Polygenic Risk Score in Primary Prevention Based on Age and Clinical Risk

Shaan Khurshid, MD
Frequency of Atrial Fibrillation in a Contemporary Elderly Primary Care Population: A Vital AF Trial Study

Fatima Stanford, MD, MPH, MPA, MBA
Clinical Risk Factors, Epidemiology and Long Term Risk for Children and Adults

Deborah Wexler, MD
Diabetology Experience/Expertise

Amit Khera, MD
Genetics of Cardiovascular Disease in South Asians

Jennifer Ho, MD
How Do Lifestyle Interventions Impact HFpEF Hemodynamics and Physiology

Jason Roh, MD
Shared Senescence Pathophysiology in Preeclampsia and Preipartum Cardiomyopathy

Krishna Aragam, MD, MS
Genome-Wide Association Study of Dilated Cardiomyopathy in the VA Million Veteran Program

Kaavya Paruchuri, MD
Polygenic Risk Score and Deep Learning Using Chest Radiographs: Complementary Prediction of Incident Coronary Artery Disease

Rajeev Malhotra, MD, MS
Genetics Determinants of Cardiovascular Calcification

Jacques Guyette, PhD, and Harald Ott, MD
Human IPS Derived Pre-Epicardial Cells Direct Cardiomyocute Aggregation Expansion and Organization in vitro

Mostafa Al-Alusi, MD
Trends in Consumer Wearable Devices with Cardiac Sensors in a Primary Care Cohort

Akihiro Nakajima, MD
Plaque Rupture, Compared to Plaque Erosion, is Associated with Higher Levels of Pan-coronary Inflammation, Measured By Peri-coronary Computed Tomography Angiography

S. Margaret Sunitha, PhD
Genome-Wide Scan Identifies Variants Increasing Triglycerides Only Among Diabetics

Mark Trinder, MD/PhD
Longitudinal Lipoprotein(a) Concentrations and Cardiovascular Risk: A Prospective Cohort Study

Katie Clapham, MD
Whole Exome Sequence Analysis of Pulmonary Hypertension in the UK Biobank

So Mi Jemma Cho, PhD
Duration of Ideal Cardiovascular Health With Risk of Chronic Kidney Disease and Cardiovascular Disease

Chris Marnell, MD
Population Effects of Clinical, Laboratory, and Genetic Risk Factors for Incident CAD: A Cohort Study in the UK Biobank

Zhi Yu, PhD
Genome-Wide Pleiotropy Analysis of Coronary Artery Disease and Pneumonia

Maryam Zekavat, MD/PhD
Deep Learning of the Retina Enables Phenome- and Genome- Wide Analyses of the Microvasculature

Sumeet Khetarpal, MD, PhD
Relationship of Serum Lipid Metabolites and Clonal Hematopoiesis of Indeterminate Potential Among 12,186 Participants of the UK Biobank

Sarah Urbut, MD (Fellow)
Bayesian Multivariate Analysis of Genetic Effects on Lipids and a Part of the Advances in Polygenic Risk Scoring for Cardiovascular Disease panel